BIOMERICA INC

BMRANasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$5.3M

▼ 1.9% YoY

Net Income

-$5.0M

▲ 16.8% YoY

EPS

$-2.16

▲ 23.9% YoY

Cash

$2.4M

▼ 42.5% YoY

FY 2025 · As of 2025-05-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.